DV Biomed Co., Ltd. (TPEX:6539)
Taiwan · Delayed Price · Currency is TWD 41.50
-0.50 (-1.19%)
Aug 19, 2026, 10:11 AM CST
DV Biomed Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 76.62 | 7.74 | 89.08 | 162.91 | 281.26 | 304.58 |
Depreciation & Amortization | 31.18 | 34.22 | 17.7 | 23.05 | 180.16 | 176.26 |
Other Amortization | 1.2 | 1.2 | 1.19 | 1.78 | 3.41 | -7.51 |
Loss (Gain) From Sale of Assets | 0.42 | 0.42 | -5.35 | 0.02 | 2.01 | 4.73 |
Loss (Gain) From Sale of Investments | -4.39 | -1.14 | -1.79 | -11.45 | -5.47 | -0.3 |
Loss (Gain) on Equity Investments | - | - | - | - | 26.15 | 27.97 |
Provision & Write-off of Bad Debts | 0.63 | 0.05 | -1.29 | 1.11 | -0.6 | -1.79 |
Other Operating Activities | -0.71 | -2.4 | 11.07 | -81.32 | -3.66 | 15.26 |
Change in Accounts Receivable | -2.11 | 3.18 | 48.73 | -45.4 | 53.24 | -33.76 |
Change in Inventory | -17.68 | -25.11 | -3.12 | 10.27 | -1.83 | -20.44 |
Change in Accounts Payable | -22.03 | 3.41 | 4.85 | 7.62 | -5.12 | 19.19 |
Change in Unearned Revenue | 14.43 | 7.46 | 2.01 | -2.41 | 0.94 | 19.77 |
Change in Other Net Operating Assets | -6.96 | 28.84 | -43.2 | -5.92 | -0.17 | 18.64 |
Operating Cash Flow | 70.24 | 57.5 | 119.04 | 69.61 | 522.58 | 522.59 |
Operating Cash Flow Growth | -51.06% | -51.70% | 71.00% | -86.68% | -0.00% | 12.85% |
Capital Expenditures | -19.85 | -28.15 | -1.52 | -2.52 | -120.76 | -62.22 |
Sale of Property, Plant & Equipment | 0.22 | 0.22 | 74.48 | - | 3.37 | - |
Divestitures | - | - | 1.73 | -9.01 | - | - |
Sale (Purchase) of Intangibles | -1.01 | -12.25 | -4.7 | - | -1.46 | -7.09 |
Investment in Securities | -46.5 | -49.42 | -117.89 | 79.44 | -77.83 | -38.26 |
Other Investing Activities | -0.74 | -3.55 | -0.31 | 2.72 | -1.32 | 2.8 |
Investing Cash Flow | -67.88 | -86.13 | -30.88 | 70.63 | -198.01 | -104.77 |
Short-Term Debt Issued | - | - | - | - | - | 30 |
Total Debt Issued | - | - | - | - | - | 30 |
Short-Term Debt Repaid | - | - | - | - | - | -30 |
Long-Term Debt Repaid | - | -21.57 | -32.4 | -10.35 | -77.2 | -67.92 |
Total Debt Repaid | -17.87 | -21.57 | -32.4 | -10.35 | -77.2 | -97.92 |
Net Debt Issued (Repaid) | -17.87 | -21.57 | -32.4 | -10.35 | -77.2 | -67.92 |
Repurchase of Common Stock | - | - | - | - | -42.16 | - |
Common Dividends Paid | - | -37.14 | -80.43 | -298.96 | -306.65 | -325.94 |
Other Financing Activities | 0.5 | 0.5 | 9.52 | 0.11 | - | - |
Financing Cash Flow | -17.37 | -58.21 | -103.3 | -309.2 | -426.01 | -393.86 |
Foreign Exchange Rate Adjustments | -1.17 | -13.18 | 2.88 | 4.22 | 0.64 | 0.05 |
Net Cash Flow | -16.18 | -100.02 | -12.27 | -164.75 | -100.79 | 24.01 |
Free Cash Flow | 50.39 | 29.35 | 117.52 | 67.09 | 401.83 | 460.37 |
Free Cash Flow Growth | -61.74% | -75.02% | 75.17% | -83.30% | -12.72% | 24.50% |
Free Cash Flow Margin | 6.34% | 3.70% | 20.49% | 10.84% | 21.53% | 25.20% |
Free Cash Flow Per Share | 2.07 | 1.21 | 4.82 | 2.75 | 16.43 | 18.68 |
Levered Free Cash Flow | 40.03 | 27.82 | 68.18 | 78.2 | 329.69 | 374.48 |
Unlevered Free Cash Flow | 40.72 | 28.75 | 69.23 | 78.3 | 332.95 | 377.26 |
Cash Interest Paid | 1.5 | 1.5 | 1.68 | 0.16 | 5.29 | 4.45 |
Cash Income Tax Paid | 11.28 | 11.28 | 18.25 | 77.32 | 84.02 | 73.45 |
Change in Working Capital | -34.35 | 17.77 | 9.27 | -35.84 | 47.06 | 3.39 |